Kush Arvind 4
4 · Inhibikase Therapeutics, Inc. · Filed Oct 23, 2024
Insider Transaction Report
Form 4
Kush Arvind
Director
Transactions
- Purchase
Common Stock
2024-10-21$1.37/sh+145,000$198,650→ 145,000 total - Award
Stock Option (right to buy)
2024-10-21+60,000→ 60,000 totalExercise: $2.22Exp: 2034-10-21→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option shares vest 50% on each of the first two anniversaries of October 21, 2024.